In mouse stroke models, we found METTL3 overexpression increased NEDD4L levels, enhanced TFRC ubiquitination and degradation, limited iron accumulation, and reduced oxidative damage and ferroptotic cell death, resulting in smaller infarct sizes and improved neurological function. The gene discussed is NEDD4L; the disease is stroke disorder.